SPOTLIGHT -
Pharmaceutical Executive, April 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.
PE eBook Series 2016 Info Sheet
Stand-Out Promotion Strategies for a Crowded Drug Marketplace Spon Opp
Market Access Capabilities for a Value-Driven Marketplace Spon Opp
Surviving in a New Era of Compliance Challenges - Spon Opp
Can FDA Control Drug Prices?
More generics and biosimilars may generate competition - but FDA opposes broad compounding.
Orphans of the Storm
Europe’s contrasting views on rare disease drugs - one bashing pricing abuses, the other extolling their public health virtues - could ultimately leave these products out in the cold.
Pharmaceutical Executive, March 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2016 issue in an interactive PDF format.
How Did Things Get This Bad? Look in the Mirror, US Pharma
As US pharma continues to ponder its “winter of discontent”, the question that leaders of industry have to be asking themselves is, “How did things get this bad?” Tom Norton reports.
PE Strat Outlook 2015
Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach
Pharm Exec AAM 062015
What Lies Ahead 2016
Make the Pain Stop: New Shared Platform Eases Investigators’ Burden
EUPATI Launches Educational Toolbox on Medicines Research & Development
Congress to Keep a Close Watch on FDA
18 February, 2016.
What are YOU Wearing Today? The Present & Future of Wearable Health Devices
The Creative Impulse: Defending Pharma and Health DTC
Defending pharma and health direct-to-consumer advertising is a top 2016 priority for the 4A’s industry trade group.
Pharmaceutical Executive, February 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2016 issue in an interactive PDF format.
Harvard Business School Launches Precision Trials Challenge
Harvard Business School has launched a competition to generate ideas to bring precision diagnostics and therapies to market more quickly by reinventing the clinical trials process.
An Eye on J.P. Morgan 2016: Pharm Exec's Top Tweets
Casey McDonald keeps an eye on the one of the healthcare industry’s biggest weeks on Twitter with regular updates here.
Rough Road Ahead for Innovation
The continuing attack on industry pricing and marketing jeopardizes coverage, R&D.
Pharmaceutical Executive, January 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2016 issue in an interactive PDF format.
Pharma Pricing Probe Puts Spotlight on Drug Compounding
The continuing campaign to ratchet down prescription drug prices has generated considerable talk about how compounders could provide less costly, alternative therapies. Jill Wechsler reports.
Special Section Media, Communications & Social Media
Podcast: FDA’s New Mobile Apps: Q&A with Paul Buckman
An Increasingly Global Approach: January 2016 Therapeutic Innovation & Regulatory Science
New EU Clinical Trials Regulation: One of the Most Important Changes in the Field in the Past Decade
Special Year-End Video Greeting
